Concepedia

Maria Passhak

MP

Statistics

Publications

6

Citations

352

H-Index

6

Active since

2016

Affiliations

Rambam Health Care Campus(Current)

National Yang Ming Chiao Tung University

Asan Medical Center

University of Chicago

Vall d'Hebron Institute of Oncology

Maria Passhak is an author at Rambam Health Care Campus specializing in oncology, medicine, and metastatic disease treatment.

ORCID

Publications per year

2016–2025

6

Publications

6

The role of tumor-infiltrating lymphocytes (TILs) as a predictive biomarker of response to anti-PD1 therapy in patients with metastatic non-small cell lung cancer or metastatic melanoma

Anton Uryvaev, Maria Passhak, Dov Hershkovits et al. · Medical Oncology · 2018 · 183 citations

, , +17

Lenvatinib Plus Pembrolizumab Versus Standard of Care for Previously Treated Metastatic Colorectal Cancer: Final Analysis of the Randomized, Open-Label, Phase III LEAP-017 Study

Akihito Kawazoe, Rui‐Hua Xu, Pilar García‐Alfonso et al. · Journal of Clinical Oncology · 2024 · 77 citations · Full text

, , +13

Tumor Treating Fields With Gemcitabine and Nab-Paclitaxel for Locally Advanced Pancreatic Adenocarcinoma: Randomized, Open-Label, Pivotal Phase III PANOVA-3 Study

Hani M. Babiker, Vincent J. Picozzi, Sreenivasa R Chandana et al. · Journal of Clinical Oncology · 2025 · 38 citations · Full text

, , +9

LBA-5 Lenvatinib plus pembrolizumab versus standard of care for previously treated metastatic colorectal cancer (mCRC): the phase 3 LEAP-017 study

Akihito Kawazoe, Rui‐Hua Xu, Maria Passhak et al. · Annals of Oncology · 2023 · 27 citations · Full text

, , +10

Long-lasting stable disease with mTOR inhibitor treatment in a patient with a perivascular epithelioid cell tumor: A case report and literature review

Ezequiel Flechter, Yaniv Zohar, Ludmila Guralnik et al. · Oncology Letters · 2016 · 15 citations · Full text

, , +17

1–5 of 6